# Enantyum® IV Versus Piroxen® IM in Emergency Pain Management

> **NCT06404177** · PHASE3 · RECRUITING · sponsor: **Riadh Boukef** · enrollment: 300 (estimated)

## Conditions studied

- Traumatic Injury

## Interventions

- **DRUG:** Dexketoprofen
- **DRUG:** Piroxicam

## Key facts

- **NCT ID:** NCT06404177
- **Lead sponsor:** Riadh Boukef
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-15
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404177, "Enantyum® IV Versus Piroxen® IM in Emergency Pain Management". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06404177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*